TCG
LLY icon

Transcendent Capital Group’s Eli Lilly LLY Stock Holding History

Transcendent Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$990K Buy
+825
New +$843K 0.38% 61
2026
Q1 		– Sell
-195
Closed -$210K – 117
2025
Q4 		$210K Buy
+195
New +$186K 0.09% 114
2025
Q1 		– Sell
-196
Closed -$151K – 276
2024
Q4 		$151K Hold
196
– – 0.08% 113
2024
Q3 		$174K Sell
196
-33
-14% -$29.7K 0.09% 115
2024
Q2 		$207K Buy
229
+34
+17% +$27.2K 0.12% 85
2024
Q1 		$152K Hold
195
– – 0.09% 106
2023
Q4 		$114K Buy
+195
New +$114K 0.08% 101

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Transcendent Capital Group's LLY Position: Q2 2026 in Review

Transcendent Capital Group opened a new position in Eli Lilly (LLY) in Q2 2026: 825 shares worth $990K. The stake represents 0.38% of the portfolio and ranks #61 among its holdings. This is a return to the name: Transcendent Capital Group previously reported a position in LLY as recently as Q4 2025.

Transcendent Capital Group first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Transcendent Capital Group held 825 shares of Eli Lilly worth $990K as of Q2 2026.
  • Eli Lilly was a new Transcendent Capital Group position in Q2 2026.
  • Eli Lilly made up 0.38% of Transcendent Capital Group's portfolio in Q2 2026, its #61 holding.
  • Transcendent Capital Group first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Transcendent Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.